共 208 条
[1]
Milliez P(2005)Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism J Am Coll Cardiol 45 1243-1248
[2]
Girerd X(2003)High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients J Hypertens 21 2149-2157
[3]
Plouin PF(2006)Resistant or difficult-to-treat hypertension J Clin Hypertens (Greenwich) 8 181-186
[4]
Blacher J(2008)Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study Lancet 371 1921-1926
[5]
Safar ME(2002)Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism Hypertension 40 897-902
[6]
Mourad JJ(2013)Resistant hypertension and target organ damage Hypertens Res 36 485-491
[7]
Stowasser M(2013)Hypertension caused by primary hyperaldosteronism: increased heart damage and cardiovascular risk Rev Esp Cardiol (Engl Ed). 66 47-52
[8]
Gordon RD(2013)Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study Hypertension 62 331-336
[9]
Gunasekera TG(1997)Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension Hypertens Res 20 85-90
[10]
Cowley DC(2018)Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study Lancet Diabetes Endocrinol 6 51-59